Acquisitions29 May 2025, 02:01 am
Suraksha Diagnostic Reports 15% Y-o-Y Revenue Growth in FY25, Acquires Fetomat Wellness
AI Summary
Suraksha Diagnostic Limited, the largest integrated diagnostic chain in East India, announced its audited financial results for the quarter and year ended 31 March 2025. The company reported a 15.2% year-on-year growth in total income, with EBITDA growing by 15.6% and PAT by 34.0%. The company also acquired a 63% stake in Fetomat Wellness Private Limited, marking its entry into genomic medicine. Seven new centers were added in FY25, with plans to add 15-18 centers in FY26. The acquisition of Fetomat is expected to bring significant synergies and open new avenues for sustainable growth.
Key Highlights
- Revenue from Operations grew by 15.3% year-on-year
- EBITDA for FY25 grew by 15.6% with a margin of 33.8%
- PAT for FY25 increased by 34.0% year-on-year
- Acquisition of a 63% stake in Fetomat Wellness Private Limited
- Plan to add 15-18 new centers in FY26